Proficio Capital Partners LLC Acquires Shares of 32,996 Avantor, Inc. (NYSE:AVTR)

Proficio Capital Partners LLC purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 32,996 shares of the company's stock, valued at approximately $695,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its stake in Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock valued at $26,000 after purchasing an additional 625 shares in the last quarter. Smartleaf Asset Management LLC increased its position in shares of Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after buying an additional 830 shares in the last quarter. Global Retirement Partners LLC raised its stake in shares of Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after buying an additional 1,067 shares during the last quarter. UMB Bank n.a. raised its stake in shares of Avantor by 56.3% during the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after buying an additional 1,074 shares during the last quarter. Finally, CKW Financial Group boosted its position in shares of Avantor by 116.7% in the 4th quarter. CKW Financial Group now owns 5,200 shares of the company's stock worth $110,000 after buying an additional 2,800 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 4,907 shares of the business's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the sale, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the sale, the executive vice president now directly owns 87,379 shares of the company's stock, valued at $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by company insiders.

Remove Ads

Avantor Trading Down 1.0 %

Shares of AVTR traded down $0.16 during mid-day trading on Tuesday, hitting $16.33. The company had a trading volume of 7,241,965 shares, compared to its average volume of 6,324,432. Avantor, Inc. has a 1-year low of $15.37 and a 1-year high of $28.00. The business's 50-day simple moving average is $18.76 and its 200-day simple moving average is $21.57. The stock has a market cap of $11.12 billion, a PE ratio of 15.70, a P/E/G ratio of 1.55 and a beta of 1.30. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period last year, the firm posted $0.22 EPS. Sell-side analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AVTR has been the subject of a number of research reports. Raymond James restated an "outperform" rating and set a $24.00 target price (down previously from $26.00) on shares of Avantor in a research report on Monday, February 10th. Wells Fargo & Company reduced their target price on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Citigroup dropped their price target on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Royal Bank of Canada reduced their price objective on Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a research report on Monday, February 10th. Finally, UBS Group reiterated a "neutral" rating and set a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, Avantor currently has a consensus rating of "Moderate Buy" and an average price target of $25.50.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.